This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Lupin, Inc.. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2019
Title: Hemraj Mahadeorao Lande: Innovator in Pharmaceutical Chemistry
Introduction
Hemraj Mahadeorao Lande is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes and polymorphs for important pharmaceutical compounds. With a total of 2 patents to his name, Lande's work is recognized for its innovation and practical applications.
Latest Patents
Lande's latest patents include a process for the preparation of apremilast and novel polymorphs thereof. This invention provides an improved method for preparing an intermediate of apremilast, along with novel polymorphs that are cost-effective, robust, and viable at plant scale. Additionally, he has developed a novel crystalline form L of (±)-desvenlafaxine benzoate, along with a process for its preparation and pharmaceutical compositions that include this new crystalline form.
Career Highlights
Lande is currently associated with Lupin, Inc., a leading global pharmaceutical company. His work at Lupin has focused on enhancing the efficiency and effectiveness of pharmaceutical formulations, contributing to the company's reputation for innovation in drug development.
Collaborations
Throughout his career, Lande has collaborated with esteemed colleagues such as Gurvinder Pal Singh and Girij Pal Singh. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical technologies.
Conclusion
Hemraj Mahadeorao Lande's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His patents reflect a commitment to improving pharmaceutical processes and formulations, making significant strides in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
